Somatic Cell Gene Editing

ISSCR/ASGCT 2022 Madison International Symposium
2022-09-20 - 2022-09-23 | Monona Terrace Community and Convention Center, 1 John Nolen Dr, Madison, WI, 53703, United States
The International Society for Stem Cell Research (ISSCR) and the American Society for Gene and Cell Therapy (ASGCT) are partnering to host an exciting program on the latest advancements in regenerative medicine at the intersection of genetic and cellular technologies.
The marriage of genomic and cellular advances holds tremendous potential for regenerative medicine. Recent discoveries in stem cell biology are being combined with powerful new gene-editing technologies to bring about potentially transformative new therapies for diseases affecting a wide range of tissue and organ systems. This three day meeting will highlight groundbreaking work developing therapies for diseases of the nervous, hematopoietic, and muscle systems, diabetes, metabolic diseases, and cancer, and feature forward-looking new technologies shaping the future of the field.
Join us on 21 – 23 September 2022 when world-renowned scientists developing gene and cell therapies will converge at the Monona Terrace Community and Convention Center in Madison, WI, a city recognized for its seminal contributions to human stem cell research. Scientists, researchers, and industry leaders will present new discoveries at the leading edge of regenerative medicine.

The State of Biotech
2022-09-20 - 2022-09-22 | VIRTUAL
This is a fascinating, exciting, and perplexing time for biotechnology. The industry delivered RNA vaccines to save countless lives during the pandemic and has created impressive early clinical results using CRISPR gene editing to treat patients with deadly genetic diseases. And yet the sector has been tarnished with safety concerns, drug failures, and lay-offs.

For more than 40 years, Genetic Engineering & Biotechnology News (GEN) has been covering the world of biotechnology. This September, we will cover it as never before – in a must-attend virtual event hosted by GEN Edge, the premium subscription news service of GEN.

THE STATE OF BIOTECH is an essential virtual summit (spanning two half days) featuring leaders from industry, academia, and finance discussing the latest critical breakthroughs, trends, and challenges in the biotech industry. The event will feature presentations and conversations with a trove of biotech leaders and entrepreneurs, brilliant scientists and innovators, and renowned analysts and commentators.

Human Gene Therapy Conference
2022-09-25 - 2022-09-28 | Melbourne Convention and Exhibition Centre (MCEC), 1 Convention Centre Pl, South Wharf, Victoria, 3006, Australia
Gene Forum takes the honour to invite you to the International Human Gene Conference which will be held on September 26-28, 2022 at Melbourne Australia.
Over the past few years, Gene therapy has become a regular talk for the scientists and researchers from academia and industry all over the globe. Gene therapy is very huge and more team’s diverse research is needed to find the effective treatments and best possible ways to manage the rare diseases. With a great substantial research on genetics happening in this part of the world, therefore it has developed into a forum to discuss important challenges in this field.
The aim of the conference is to bring together all the key stakeholders interested in genetics and gene therapy to share and discuss advances and developments in these fields. Therefore we aimed at assisting academicians, business executives, researchers, scientists, manufacturers, gene therapy companies, communities, and agencies to keep on new developments in their specific fields and to join forces in finding alternative solutions.
It’s a unique way to approach and encourage a dialogue between speakers and delegates through its well-planned agenda with the series of talks, poster presentations, panel discussions and networking events that will keep participants engaged in learning. This will help rising scientific queries and provide solutions for a smarter and more advanced future.
We are stepping forward to create a platform to bring all the researchers from around the world and the research community to collaborate with the industries to focus on their efforts. The industry partners and attending experts will also provide a fantastic networking experience.

World Molecular Imaging Congress 2022
2022-09-27 - 2022-10-01 | Miami Beach Convention Center, 1901 Convention Center Drive, Miami, FL, 33139, United States
The World Molecular Imaging Congress brings together people from across the globe who represent the entire spectrum of Molecular Imaging. These individuals gather at WMIC to exchange ideas and foster innovation. The scientific and educational sessions are replete with leaders in the field and young scientists alike, each of whom has made significant contributions to our understanding of biology, advanced technology innovation, and/or evaluated new developments in the clinic. These sessions are complemented by thousands of abstracts that detail advances and highlight the latest developments in Molecular Imaging. Our industry exhibitors and sponsors showcase their innovations in the exhibition hall and lecture hall, detailing advances that will refine your animal models, accelerate your research, and improve clinical care. Each WMIC session is packed with innovative ideas and cutting-edge research. Molecular Imaging is a window into biology that enables discovery. We use these windows to investigate new biology and increase understanding, and the better we understand biological processes of living systems, with all of the contextual influences intact, the more effective our therapies will be in the clinic. Molecular Imaging lies at the heart of precision medicine. WMIC is the event that showcases all of the innovations in Molecular Imaging and shows the utility of novel imaging strategies in clinical investigation and the study of disease. Molecular Imaging as a field lies at the nexus of innovation in chemistry, hardware development, software innovation, biology, and medicine, and the WMIC is where you will hear about the most exciting highlights and the most in-depth evaluation. You will not want to miss WMIC 2022 in Miami!

18th Annual Meeting of the Oligonucleotide Therapeutics Society
2022-10-01 - 2022-10-05 | Hilton Phoenix Resort at the Peak, 7677 N 16th St, Phoenix, AZ, 85020, United States
The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society’s mission and goals, to foster academic and industry-based research and development of oligonucleotide therapeutics. Leaders in the field from across the globe alongside students will present on an array of topics, including chemistry, AI/machine learning, genome & RNA editing, and preclinical and clinical research.
The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics.

2022 VEGA Symposium
2022-10-05 - 2022-10-07 | Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA, 94720, United States
The VEGA 2022 symposium aims to bring together a “viral ecogenomics” community to foster discussion on how to best capture and characterize uncultivated viruses, understand the role of viruses in natural ecosystems, and functionally explore viral genetic diversity toward innovative biotechnological and industrial applications. This 2022 edition will focus in particular on experimental innovations, computational advances, and other technological developments that will enable researchers to functionally characterize novel viral diversity and investigate virus-virus and virus-host interactions in nature. The symposium will also include organized discussion sessions to gather input from the community on the most pressing challenges faced by researchers in the viral ecogenomics fields.
Participants will notably be invited to open discussions designed to shape the future design of IMG/VR (the database of uncultivated viral genomes) to maximize its usefulness for the different actors in the field (i.e. gene-centric experimental approaches, ecosystem models, host-based evolutionary analysis, etc), as well as frame a potential viral-focused calls for projects at the JGI.

Drug Repurposing for Rare Diseases 2022
2022-10-09 - 2022-10-10 | America Square Conference Centre, 17, One Crosswall, America Square, London, EC3N 2LB, United Kingdom
Our annual conference highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments.
The drug repurposing field has shifted after stepping into the limelight during the COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognizing the opportunities to repurpose a drug to treat an often rare and neglected condition.
Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines – the answers have been right under our noses all along!

29th Congress of the European Society of Gene and Cell Therapy
2022-10-10 - 2022-10-14 | Edinburgh International Conference Centre, The Exchange, 150 Morrison St, Edinburgh, United Kingdom

2022 Cell & Gene Meeting on the Mesa
2022-10-10 - 2022-10-13 | Carlsbad, CA
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Cardiovascular Disease Model Satellite 2022, 20th International SHR Symposium & 58th Japanese SHR Meeting
2022-10-15 - 2022-10-17 | Shirankaikan Annex, 11-1 Yoshidaushinomiyacho,, Kyoto, Sakyo Ward, 606-8302, Japan
Cardiovascular disease model research has seen remarkable advances in the last decade. The technology is staggering, the magnitude of human studies is extraordinary, the sophistication of animal models is outstanding, and the revelations regarding the insights into the genomics and other omics are absolutely fascinating. Yet the future prospects are even more exciting. These will be core elements of the Cardiovascular Disease Model Satellite 2022, with the main theme
“Innovative science of hypertension-related disease model towards precision medicine and prevention” to envision the future, building on today’s achievements.
Cardiovascular Disease Model Satellite 2022 is an official investigator-led satellite to the
International Society of Hypertension Meeting in October 2022 and we are delighted that it will also incorporate the 20th International SHR Symposium and the 58th Japanese SHR Meeting. We should like you to be part of this stimulating meeting. The quality of our Committees and International Advisory Board will ensure that the research presented is at the forefront of the field. This will include the latest in genomics and other omics discovery, control and integration of gene expression, biomarkers, systems biology, pharmacogenomics, epigenetics and functional validation. The Satellite will span 1.5 days and will be held on Sunday 16 and Monday 17 October 2022. Although the Satellite was scheduled to be held in a hybrid format (face-to-face and virtual), I announce with great regret that we have decided to hold the meeting in a semi-hybrid format. That is, except for the speakers who can come to deliver their presentation at the venue located within the Kyoto University, the other speakers and the audience will participate in the meeting online. As an Investigator-Led Satellite, we are keeping costs to minimum and you will find details regarding Abstract Submission, Registration and related matters on this website.
We look forward to your participation in a memorable meeting and contribution to future of Cardiovascular Disease Model Research.

NYSCF Conference
2022-10-17 - 2022-10-19 | The Rockefeller University, 1230 York Ave, New York, NY, 10065, United States
The NYSCF Conference is the premier translational stem cell research conference. Held annually for the past 16 years, it has brought together world-leading experts from various disciplines across biomedicine and biotechnology to present the latest cutting-edge stem cell science.

Tri-Omics Summit Europe
2022-10-17 - 2022-10-20
Extraordinary times call for extraordinary events! Therefore, it’s our pleasure to invite you to the Tri-Omics Summit, coming to London in October 2022 as a one-stop-shop for multi-disciplinary teams to come together to address the challenges of “omics” data analysis and effectively deliver precision medicine.
Join us from 18th-20th October as we explore the realms of multi-omics, single cell & spatial analysis and cancer genomics from discovery, through translation and into meaningful clinical outcomes for patients.
Driven by our social mission, we are pleased to offer free tickets to everybody employed exclusively by a research institution, hospital, clinic or a pharma company with an existing drug pipeline.
You can expect to hear from experts in the fields of multi-omics, single cell & spatial omics and cancer genomics.

ASHG 2022 Annual Meeting
2022-10-25 - 2022-10-29 | Los Angeles Convention Center, 1201 S Figueroa St, Los Angeles, CA, 90015, United States
We are excited to welcome you back in-person to Los Angeles for ASHG’s annual meeting, taking place this October 25-29. Attendees can look forward to reconnecting with peers, engaging in discussions on research findings and sessions, all while enjoying the beautiful attractions and backdrop LA has to offer for this long-awaited reunion.

Process Intensification: Improving the Process Status Quo
2022-10-27 10:00 - 12:00 (America/Chicago) | VIRTUAL
The goal is to make more products faster and more efficiently, without sacrificing quality. Before implementing change, you need to answer several core questions, including: How can I intensify an established process with minimal risk? Why should I change a working, validated process? What are the appropriate technology options and what metrics should be considered to justify their investment?
Our speakers provide insight on their experiences, decision-making processes and outcomes.

Cell Symposia: Hallmarks of Cancer
2022-10-29 - 2022-11-01 | Paradise Point Resort & Spa, 1404 Vacation Rd, San Diego, CA, 92109, United States
Hallmarks of Cancer Cell Symposium is one of the most popular and longest-lasting conference series of Cell Press, and has been successfully held in the United States, Europe, and China previously. High-quality talks from highly respected cancer researchers and oncologists will strengthen and extend our understanding of cancer biology and accelerate the translation of the cutting-edge knowledge into more effective therapies. As a tradition, our “Meet the Speakers” dinner provides an additional great platform to communicate with leaders in the community in an interactive, productive, and relaxed environment. The year of 2022 also marks the 20th anniversary of Cancer Cell, and the meeting attendees are all invited to join our celebration of 20 years of serving this great community. After the disruption in scientific communication and social isolation imposed by lockdowns and travel restrictions, we are excited to meet you and talk about science in person. Come and join us in San Diego this fall.

5th International Conference on CRISPR Technologies
2022-10-30 - 2022-11-02 | UC Berkeley, Berkeley, CA, United States
CRISPR 2022 brings together investigators focused on enzymes and technologies, predominantly CRISPR-based systems, but also other promising systems and approaches, to discuss advances in the field and ways to harness genome engineering for beneficial purposes. Topics range from fundamental biology to translational and applied applications and include studies across the diversity of life. Importantly, speakers and participants represent both academic and commercial interests.

14th Annual Protein & Antibody Engineering Summit
2022-11-13 - 2022-11-16 | InterContinental Barcelona, Av. de Rius i Taulet, 1-3, 08004, Barcelona, 08004, Spain
Network with 1,200 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as “the best biologics technology meeting in Europe.” Last year, nearly 900 delegates from 35 countries, including 78% from pharma and biotech organizations, convened in beautiful Barcelona and online to discuss the latest advances in protein and antibody engineering.

ISSCR 2022 Boston International Symposium
2022-11-16 - 2022-11-19 | Boston Marriott Cambridge, 50 Broadway, Cambridge, MA, 02142, United States
Join us for the ISSCR 2022 Boston International Symposium on Cell Manufacturing and Commercialization “Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success,” which will take place at the Boston Marriott Cambridge Boston, MA from 17-19 November 2022.
The meeting will bring together international academic and commercial scientists with expertise in the preclinical, clinical, and regulatory phases to discuss the critical processes and strategies in the successful development of PSC-derived therapies. Sessions will cover some of the latest thinking and approaches for selecting the cell line, characterizing the product and manufacturing considerations, managing the immune system, and working with regulators throughout the process. We hope you can join us in one of the world’s hubs of biotechnology.

Cell Bio 2022
2022-12-02 - 2022-12-07 | Walter E. Washington Convention Center, 801 Mount Vernon Place NW, Washington DC, DC, 20001, United States
After two years, Cell Bio 2022 will return as an in-person meeting December 3-7, 2022, in Washington, DC. We are excited to make it possible for colleagues to reconnect face-to-face, while keeping health and safety paramount. We understand flexibility is also important. In addition to our in-person meeting, limited content will be available on-demand for purchase after the meeting so that all scientists can access the cutting-edge cell biology research that was presented during the in-person meeting.

Advances in Therapeutic Applications of Stem Cells
2022-12-07 - 2022-12-10 | Cedars-Sinai Medical Center, 8700 Beverly Blvd #2900A, Los Angeles, CA, 90048, United States
Stem cells are moving toward the clinic as cellular therapeutics in several indications and are being tested in clinical trials in others. They are also employed to advantage in the discovery of novel therapeutics in several modalities, including physiologically relevant toxicity and drug screening platforms, and lend themselves to other treatment modalities, including gene therapy, and personalized precision medicine.
The goal of this Cell Symposium is to bring together clinicians, academic researchers, and industry and regulatory stakeholders to discuss advances in the field and to champion new ideas to overcome the current challenges across the clinical and translational spectrum of stem–cell-based research and therapy.

International Conference on CRISPR and Gene Editing
2022-12-14 - 2022-12-16 | VIRTUAL
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on CRISPR and Gene Editing aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of CRISPR and Gene Editing. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of CRISPR and Gene Editing.

Cell Therapy Manufacturing Strategies: Autologous vs. Allogeneic
2022-12-15 10:00 - 12:00 | VIRTUAL
There have been tremendous advancements and breakthroughs in cell therapy treatments. Autologous treatments are extremely effective personalized therapies, but have significant medical, cost and commercialization limitations. Allogeneic treatments provide us with an opportunity to expand and extend access to personalized therapies to patients in need, but face efficacy, safety, and process hurdles.
While related, the differences are stark, forcing your company to make unique and critical process and business decisions to ensure your company implements the best technologies to execute the most effective autologous and/or allogeneic cell therapy manufacturing strategy.

Pre-Filled Syringes and Injectable Drug Devices Europe
2023-01-09 - 2023-01-12 | Copthorne Tara Hotel London Kensington, Scarsdale Pl, London, W8 5SY, United Kingdom
SAE Media Group’s 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below:
• Novel Drug Products and Large Volume Delivery
• Sustainability for Injectable Delivery Devices
• Primary Packaging Development
• Connected Drug Delivery Devices

PepTalk: The Protein Science and Production Week
2023-01-15 - 2023-01-20 | Hilton San Diego Bayfront, 1 Park Blvd, San Diego, CA, 92101, United States
PepTalk connects protein science researchers from around the globe to share case studies, unpublished data, breakthroughs, and solutions that support and enhance biotherapeutics R&D.

This year’s event will feature world-renowned speakers, cutting-edge technologies, and engaging networking events. Programming includes in-depth coverage of antibody discovery, protein engineering, bispecific antibodies, emerging immunotherapies, protein aggregation, machine learning, cell and gene therapy, protein expression, purification and production.

2nd annual Transdermal and Microneedle Drug Delivery Conference
2023-01-22 - 2023-01-24 | Copthorne Tara Hotel London Kensington, Scarsdale Pl, London, W8 5SY, United Kingdom
SAE’s 2nd annual Transdermal and Microneedle Drug Delivery conference will explore advances in microneedle diagnostics through case studies and real-world examples, whilst engaging in modern strategies for topical and transdermal drug delivery. The two-day agenda offers you peer-to-peer networking with CEO’s, Senior Vice presidents, Directors of Delivery Technologies, Heads of Product Development and many more.
Key considerations for the conference will be transdermal and microneedle systems as a mode of therapeutic drug delivery in combination with optimization of device design and development. Vaccine delivery will a significant aspect of this year’s agenda with a focus on microneedle delivery technologies as a mode for vaccine delivery, in the pursuit to increase vaccine stability and accessibility. An outlook of the transdermal space will also be reviewed, including future directions and next steps required to advance the current field and accelerate access for patients and end users.

Next Generation Ophthalmic Drug Delivery Summit
2023-01-23 - 2023-01-26 | Hyatt Centric Fisherman’s Wharf, 555 North Point St, San Francisco, CA, 94133, United States
The inaugural Next Generation Ophthalmic Drug Delivery Summit is coming to San Francisco in January 2023, to help ophthalmic drug developers overcome translational challenges of developing novel long-lasting ophthalmic therapies via novel delivery methods to reduce healthcare burden and increase patient compliance.
Join 21+ expert speakers from the likes of Genentech, Aerie Pharmaceuticals, Novartis, Clearside Biomedical, Janssen, Eyevensys, and EyePoint Pharmaceuticals to overcome your translational challenges and enhance extended drug efficacy while avoiding systemic and local adverse effects. Don’t miss your only opportunity for an industry-specific meeting for networking and sharing extended-duration therapies with the ophthalmic drug development community.

The Festival of Genomics & Biodata
2023-01-24 - 2023-01-26 | Business Design Centre, 52 Upper St, London, N1 0QH, United Kingdom
WELCOME BACK to the annual get-together for the entire genomics and biodata community, to discover, meet, learn and celebrate! This year’s Festival will bring you inspirational speakers, the latest research and clinical breakthroughs, cutting-edge technology and incredible networking opportunities.
Free for 90% of attendees, the Festival is designed to help you return to work armed with dozens of new ideas and contacts, but also to keep you engaged, excited and proud of the difference your efforts make for patients.
We can’t wait to welcome you back in-person, for what promises to be our largest in-person and most vibrant Festival yet. Explore this year’s agenda and speakers, find out what activities are taking place, and don’t forget to register early as tickets are limited.

3rd TGF-β for Immuno-Oncology Drug Development Summit
2023-01-29 - 2023-02-01 | Marines’ Memorial Club & Hotel, 609 Sutter St, San Francisco, CA, 94102, United States
In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.
From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.
Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time – don’t miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!
Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.

2nd Allogeneic Cell Therapies Summit Europe
2023-01-29 - 2023-02-01 | Leonardo Royal London City, 8-14 Cooper's Row, London, EC3N 2BQ, United Kingdom
Allogeneic approaches are deemed the future of cell therapy due to their potential to reduce costs, increase accessibility and enhance availability. However as clinical readouts emerge, challenges associated with limited durability, solid tumour targeting and therapy immunogenicity are hindering their efficacies.
The Allogeneic Cell Therapies Summit Europe is returning in January to capture the clinical advances of European drug developers whilst addressing the specific challenges they face in development. These include European regulatory affairs, donor selection, scalable manufacturing and therapy persistence.
With continued investment and growth in the allogeneic space, join European leaders from Gadeta, Antion Biosciences, TC BioPharm, and many more, as well as the US leaders undertaking European trials. This includes Atara Bio and Adicet Bio, as they progress development of multiple cell types to produce the next-generation of safe, effective and accessible cell therapies in Europe.

Viral Vector Process Development Summit
2023-01-30 - 2023-02-02 | Omni Parker House, 60 School St, Boston, MA, 02108, United States
As cell & gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability. The recent investments such as Novartis-Samsung Biologics $81m contract for viral vector manufacturing, Resilience raising $625m towards biomanufacturing capabilities including stable cell lines for viral vector production pave the foundation for scientific and technology innovations.
With better understanding of these novel nanoparticles, developability and cell line development, the ability to optimize AAV, LV formulation and define robust CQAs are critical to drug developers’ ability to increase scalability with efficiency, reduce cost of goods and most importantly, ensure product quality control for patients.
